Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Japanese Journal of Clinical Oncology|April 13, 2010
Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trialTakeshi Tominaga, Izo Kimijima, Morihiko Kimura, et al.Anticancer Research|September 15, 2005
Cell cycle arrest and apoptosis induced by SART-1 gene transductionMami Hosokawa, Ritsuko Kadota, Shigeki Shichijo, et al.Breast Cancer (Tokyo, Japan)|July 4, 2009
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in JapanMorihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, et al.International Journal of Clinical Oncology|February 25, 2005
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumorsToshiaki Saeki, Shigemitsu Takashima, Masanori Terashima, et al.Breast Cancer (Tokyo, Japan)|November 20, 2004
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working GroupToshiaki Saek, Shigemitsu Takashima, Muneaki Sano, et al.Journal of Cancer Research and Clinical Oncology|January 20, 2009
Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implicationsYoshihiko Segawa, Saburo Takata, Masanori Fujii, et al.International Journal of Cancer|May 7, 2002
Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancerKazuo Shirakawa, Masabumi Shibuya, Yuji Heike, et al.Anticancer Research|May 4, 2005
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip systemYuji Heike, Mami Hosokawa, Shozo Osumi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 TrialToru Watanabe, Muneaki Sano, Shigemitsu Takashima, et al.International Journal of Clinical Oncology|March 1, 2008
No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in JapanToshiaki Saeki, Muneo Sano, Yoshifumi Komoike, et al.Pageof 10